1513 — Livzon Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- HK$26.03bn
- HK$19.60bn
- CNY11.81bn
- 98
- 77
- 51
- 91
Annual cashflow statement for Livzon Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -4,618 | -6,247 | -5,658 | -5,018 | -5,217 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,161 | 1,902 | 2,773 | 3,249 | 2,979 |
| Capital Expenditures | -647 | -1,309 | -940 | -820 | -570 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 179 | -568 | -290 | 112 | -90.2 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -468 | -1,877 | -1,230 | -708 | -660 |
| Financing Cash Flow Items | -329 | -527 | -371 | -599 | -1,192 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -518 | -815 | -720 | -1,657 | -2,486 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,098 | -827 | 947 | 904 | -159 |